Business Strategy

The robustness of business strategies are reviewed by the management at regular intervals. The business plans are modified & improvements made as on ongoing process.

The medium term strategy of the company is to attain cost efficient quality leadership in the segments of anti ulcerants, analgesics, anti-biotic, anti-oxidants and supplements. It is the endeavor of the company to achieve this by improving process efficiencies, adapting world class manufacturing facilities and developing cost effective market networks through out the country.

In the long run the company wants to be the most valued pharma company by continuously researching, developing and manufacturing a wide range of pharma products complying to the highest regulatory standards. Company’s objective is to be among the top 100 pharma company by 2016.

Expansion will be both in terms of geographical coverage and new products introduction. Export will be made to the “not highly regulated” market with impressive growth opportunity.